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Summary  Microbiology  laboratories  play  an  important  role  in  epidemiology  and
infection  control  programs.  Within  microbiology  laboratories,  molecular  microbiol-
ogy  techniques  have  revolutionized  the  identiﬁcation  and  surveillance  of  infectious
diseases.  The  combination  of  excellent  sensitivity,  speciﬁcity,  low  contamination  lev-
els  and  speed  has  made  molecular  techniques  appealing  methods  for  the  diagnosis
of  many  infectious  diseases.  In  a  well-equipped  microbiology  laboratory,  the  facility
designated  for  molecular  techniques  remains  indiscrete.  However,  in  most  develop-
ing  countries,  poor  infrastructure  and  laboratory  mismanagement  have  precipitated
hazardous  consequences.  The  establishment  of  a  molecular  microbiology  facility
within  a  microbiology  laboratory  remains  fragmented.  A high-quality  laboratory
should  include  both  conventional  microbiology  methods  and  molecular  microbiology
techniques  for  exceptional  performance.  Furthermore,  it  should  include  appropriate
laboratory  administration,  a  well-designed  facility,  laboratory  procedure  standard-
ization,  a  waste  management  system,  a  code  of  practice,  equipment  installation  and
laboratory  personnel  training.  This  manuscript  lays  out  fundamental  issues  that  need
to  be  addressed  when  establishing  a molecular  microbiology  facility  in  developing
countries.
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Introduction
Microbiology  laboratories  play  an  important  role  in
the management  of  infectious  diseases  in  terms
of national  or  global  epidemiology.  In  the  twenty-
ﬁrst century,  molecular  microbiology  techniques  for
epidemiology  and  infection  control  programs  have
become  more  demanding.  Molecular  techniques
in high-quality  clinical  microbiological  laboratories
are  routinely  used  to  make  clinical  decisions  on  the
basis of  how  and  when  to  treat  patients.  Molecu-
lar techniques  are  also  useful  for  monitoring  the
effectiveness  of  therapeutic  regimes  and  identi-
fying potential  resistant  strains  that  may  impact
a long  term  treatment  program.  The  manage-
ment and  control  of  infectious  diseases  requires
accurate diagnosis  and  knowledge  of  pathogen
distributions. The  inclusion  of  molecular  typing
techniques  for  almost  all  infectious  disease  agents
within  a  clinical  microbiology  laboratory  provides
a detailed  assessment  of  any  given  strain’s  inter-
relationships,  and  thus  can  identify  the  source
of the  organism  [1]. Almost  all  epidemiologi-
cal studies  depend  on  molecular  techniques  for
uncontrollable  rates  of  infection  and  mortality
[2,3].  In  some  resource-limited  countries,  sentinel
hospitals  lack  even  basic  microbiology  laboratory
facilities [4]. In  other  regions,  laboratories  have
all of  the  requisite  reagents  and  instruments  but
lack skilled  staff.  Other  laboratories  can  amplify
DNA but  are  unable  to  report  the  necessary  results
in time.  Furthermore,  many  laboratories  neglect
accreditation,  quality  assurance  and  quality  control
programs.  For  these  reasons,  infectious  diseases
in most  developing  countries  remain  unknown
and uncharacterized  [5].  The  Centers  for  Disease
Control  (CDC)  has  initiated  various  strategies  in
developing  countries  that  require  clinical  micro-
biology  laboratories  to  provide  accountable  data
as part  of  an  active  surveillance  of  infectious
diseases. However,  clinical  microbiology  labora-
tories  have  not  been  recognized  as  a priority
by government  bodies  in  developing  countries.
As mentioned  above,  part  of  the  problem  is
associated with  a  lack  of  skilled  laboratory  per-
sonnel  and  prohibitive  laboratory  maintenance
costs where  resources  are  available  but  inappropri-
ately used  [6]. This  manuscript  discusses  the  rolethe identiﬁcation,  characterization  and  genetic
typing of  microbes.  Nevertheless,  the  lack  of  infra-
structure  for  infectious  disease  management  in
developing  countries  has  been  blamed  for  the
o
a
t
cf molecular  techniques  in  clinical  microbiology
nd epidemiology  and  the  various  issues  required
o establish  molecular  laboratories  in  developing
ountries.
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tstablishing  molecular  microbiology  facilities  in  dev
he role of molecular techniques in
linical microbiology and infection
ontrol programs
onventionally,  the  function  of  a  clinical  microbiol-
gy laboratory  is  to  identify  various  pathogens  using
irect examination  of  microbes  and  culture-based
ethods. At  present,  nucleic  acid  ampliﬁcation
nd DNA  probes  are  useful  for  the  characteriza-
ion of  microbes  because  cultured-based  methods
re insufﬁcient,  expensive  and  tedious.  Typi-
ally, nonampliﬁed  DNA  probe-based  methods  are
uitable for  in  situ  hybridization  of  organisms
hen the  location  and  distribution  are  ascer-
ained, including  slow  growing  microbes  such  as
eisseria  gonorrhoeae  and  Mycobacterium  tuber-
ulosis.  Pathogenic  dimorphic  fungi  have  also  been
etected  radiometrically.  Many  DNA  probe  methods
re commercially  available  for  the  identiﬁcation
f various  microbial  species,  such  as  Chlamydia
rachomatis, Legionella  pneumophila,  Trichomonas
aginalis, Candida  species,  and  human  papillo-
avirus (HPV).  In  addition  to  the  beneﬁt  of the
onﬁrmation  of  culture  methods,  DNA  probes  are
seful for  identifying  enterotoxin-producing  strains
f Escherichia  coli  because  these  strains  are  bio-
hemically  similar  to  other  non-enterotoxigenic
. coli.  Although  traditional  DNA  probe  methods
ave a  lower  sensitivity  than  nucleic  acid  ampliﬁ-
ation  techniques,  DNA  probes  are  useful  for  the
irect  identiﬁcation  of  clinical  specimens  in  cer-
ain situations.  For  example,  DNA  probes  are  used
o identify  group  A  streptococci  in  strep  throat
nfections and  C.  trachomatis  or  HPV  in  cervical
nfections. Furthermore,  the  high  level  sensitiv-
ty of  nucleic  acid  ampliﬁcation  makes  it  an  ideal
hoice  for  the  direct  detection  of  specimens.  How-
ver, expensive  molecular  procedures  should  not
eplace cost-effective  conventional  methods  that
re rapid,  sensitive  and  candid.  For  instance,  the
se of  shell  vials  and  monoclonal  antibodies  for
he diagnosis  of  cytomegalovirus  viremia  in  an
mmunosuppressed  bone  marrow  transplant  recip-
ent is  an  excellent  method  with  high  speciﬁcity
nd sensitivity  and  results  that  are  available  within
6 hours.  Thus,  it  would  be  unfavorable  to  disre-
ard this  method  and  replace  it  with  costlier  nucleic
cid ampliﬁcation  methods  without  additional  doc-
mentation  of  the  substantial  beneﬁts  of  the  latter
ethods.
When considering  the  correct  molecular  methodo be  used  in  the  laboratory,  careful  and  ﬁrm
ecision-making  should  be  directed  toward  the
otential  beneﬁts  of  modern  methodology.  Deci-
ions should  not  be  made  based  solely  on
r
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he  cost-effectiveness  of  the  molecular  method.
nstead, the  impact  of  the  method  on  the  clini-
al practice  and  patient  management  should  also
e considered.  For  instance,  direct  detection  of
ethicillin-resistant  Staphylococcus  aureus  and  M.
uberculosis  in  a patient’s  specimens  would  result
n quicker  patient  isolation,  better  targeted  ther-
py and  overall  cost  savings.  In  other  situations,
icrobes can  be  extremely  fastidious,  difﬁcult  to
ulture and  hazardous  to  laboratory  staff.  These
icrobial  samples  are  often  sent  to  referral  cen-
ers; however,  fragile  microbes  could  lose  their
iability, become  overgrown  or  even  become  con-
aminated  during  the  transferal  process.  Often,  a
ample with  a limited  volume  submitted  to  the
aboratory  becomes  impossible  to  culture.  In  such
ases, accurate  usage  of  the  sample  is  needed  to
ulture all  pathogens.  In  many  resource  limited
ountries, biosafety  level  3  laboratories  may  not  be
vailable or  may  be  economically  inappropriate  to
ulture pathogenic  microbes  [7]. Molecular  tech-
iques have  resolved  many  of  these  problems  by
dentifying  microbes  more  rapidly  and  accurately
han conventional  techniques.  For  instance,  more
han 100  genotypes  of  HPV  have  been  found  using
NA sequence  heterogeneity  as  the  basis  for  inves-
igation.
It is  important  to  remember  that  despite
heir sensitivity,  accuracy  and  speed,  nucleic  acid
mpliﬁcation  methods  cannot  totally  replace  con-
entional  culture  and  serologic  methods  because
ucleic acid  ampliﬁcation  and  conventional  meth-
ds produce  different  results.  Nucleic  acid  ampli-
cation  methods  detect  the  presence  of  DNA  or
NA in  a  particular  specimen,  but  they  cannot
emonstrate the  viability  of  an  organism  or  deter-
ine  whether  the  organism  is  part  of  the  infectious
rocess. Furthermore,  nucleic  acid  ampliﬁcation
ethods are  prone  to  errors,  and  large  amounts  of
mpliﬁed  products  can  lead  to  momentous  cross-
ontamination  and  cause  false  positive  results.
onventional methods  such  as  culture-based  tech-
iques validate  the  viability  of  an  organism,  and
uantiﬁcation  of  the  antibody  titer  strongly  sug-
ests its  involvement  as  part  of  the  infectious
rocess. Commercial  DNA  probes  have  brought
olecular techniques  into  the  ﬁeld  of  clinical
icrobiology and  have  been  used  for  several  years.
oday, most  of  the  procedures  have  been  stan-
ardized  and  are  frequently  simpler  than  target
mpliﬁcation  assays.  Additionally,  the  advent  of
he synthetic  short  oligonucleotide  DNA  probe  has
educed the  time  required  for  hybridization  assays.
he niche  for  DNA  probe  technology  in  clinical
icrobiology appears  to  be  in  situ  hybridization
or tissue  specimens  and  culture  conformation  of
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slow-growing  microbes.  Although  DNA  probes  are
more expensive  than  other  biochemical  tests,  their
rapid turnaround  time  can  be  translated  into  overall
savings by  providing  a  timely  diagnosis.  Using  stan-
dardized  methodology,  DNA  probes  can  broaden  the
various types  of  pathogens  that  a  microbiology  lab-
oratory can  routinely  identify.  The  three  different
formats commonly  used  today  are  solution-phase
hybridization,  in  situ  hybridization  and  solid-phase
hybridization.  At  present,  the  nucleic  acid  ampli-
ﬁcation  technique  is  routinely  used  in  numerous
microbiology laboratories.  This  technique  improves
the sensitivity  of  assays  based  on  nucleic  acids  and
can simplify  assays  by  automating  and  incorporating
non-radioactive  detection  formats.  The  technology
behind  the  nucleic  acid  ampliﬁcation  method  is
diverse and  in  constant  ﬂux.  There  are  three  dif-
ferent categories:  (i)  target  ampliﬁcation  by  PCR,
which relies  on  self-sustaining  sequence  replica-
tion or  strand  disruption  ampliﬁcation;  (ii)  probe
ampliﬁcation  including  a  ligase  chain  reaction;  and
(iii) signal  ampliﬁcation.  All  of  these  techniques
are currently  used  to  varying  degrees,  and  many
have been  cleared  by  the  American  Food  and  Drug
Administration (FDA).  A  detailed  account  of  all  of
the molecular  methods  used  in  clinical  microbiology
laboratories is  beyond  the  scope  of  this  manuscript.
However, some  commercially  available  molecular
assays for  various  infectious  agents  are  discussed  in
Table  1.
Molecular  typing  techniques  have  greatly  facil-
itated  epidemiologists  and  infection  control  spe-
cialists.  The  main  purpose  of  an  infection  control
program is  to  identify  possible  infection  problems
and monitor  infection  trends.  Infection  control  pro-
grams depend  on  cooperation  from  microbiology
laboratories,  which  must  provide  easy  access  to
high-quality  data  and  guide  the  use  of  resources
for epidemiological  purposes.  Furthermore,  labo-
ratory ﬁndings  are  used  to  support  epidemiologic
evidence of  the  spread  of  common  microbes  and
determine  the  modes  of  transmission  [8].  Molecu-
lar typing  techniques  have  been  successfully  used  in
microbiology  laboratories  for  the  epidemic  surveil-
lance of  various  pathogens  [9]. Several  molecular
typing methods  have  been  proposed,  such  as  pulse
ﬁeld gel  electrophoresis  (PFGE),  ribotyping  and
nucleic acid  ampliﬁcation-based  typing  schemes.
Currently,  pulse  ﬁeld  gel  electrophoresis  is  widely
used for  the  molecular  typing  of  various  bacte-
rial species.  This  technique  allows  investigators
to separate  larger  pieces  of  DNA  using  restriction
enzymes and  has  been  used  to  characterize  bac-
terial species  from  different  geographical  regions.
This technique  has  better  discriminating  power
than other  typing  schemes,  such  as  ribotyping  and
B
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ulti  locus  sequence  typing  based  on  DNA  ampliﬁ-
ation reactions.  The  results  can  be  visualized  with
 dendrogram  generated  by  matrix  pair  differences
etween the  electrophoretic  types.  Despite  PFGE
eing considered  by  analogy  as  a ‘gold  standard’  by
any investigators,  many  strains  cannot  be  typed
ue to  degradation  of  the  DNA  in  the  gel.  More-
ver, the  apparatus  and  the  specialized  chemicals
re expensive,  time  consuming  and  require  skilled
echnicians.  PFGE  has  a  lower  resolution  power
han multi  locus  sequence  typing  (MLST),  which  is
 nucleic  acid  ampliﬁcation-based  method,  and  as
uch it  is  widely  accepted  as  ‘the  typing  success
f the  decade’  because  it  can  be  applied  to  bacte-
ia and  other  microbes.  This  technique  can  be  used
o study  the  evolutionary  relationships  between
acteria due  to  its  high  discriminatory  power.  MLST
s portable,  and  unlike  PFGE  its  results  can  be  use-
ully shared  between  laboratories.  A  huge  number
f microbes  have  been  studied  under  these  two
chemes  [10]. Moreover,  MLST  requires  a  normal
hermocycler for  ampliﬁcation  that  can  also  be  used
or many  other  direct  detection  assays  and  for  the
dentiﬁcation  of  various  genes,  while  MLST  requires
n expensive  nucleic  acid  sequencing  apparatus.
owever, post-ampliﬁcation  products  can  also  be
equenced using  commercially  available  sequenc-
ng apparatuses  by  paying  for  just  the  cost  of
he reaction.  To  date,  various  molecular  typing
echniques have  been  used  to  map  various  epi-
emiological traits.  However,  the  selection  of  these
echniques  depends  on  the  aim  and  objectives  of
he particular  epidemiological  study.  This  is  espe-
ially true  in  developing  countries  or  regions  where
esources  are  limited  and  skilled  personnel  are  in
emand.
ew molecular technologies
urrently,  the  application  of  nucleic  acid  ampliﬁ-
ation  and  other  molecular  platforms  is  limited  to
arge laboratories  and  referral  centers.  The  abil-
ty to  use  these  techniques  efﬁciently  is  another
mportant factor  that  determines  how  large  a  role
hese techniques  will  play  in  an  average  microbiol-
gy laboratory.  There  is  a  growing  need  for  newer
echnologies that  are  rapid,  cost  effective  and  suit-
ble for  low  resource  countries.
eal-time droplet PCRecause  PCR  requires  thermal  cycling,  it  is typically
erformed  in  a  bench  top  unit.  This  process  is  slow,
xpensive,  error-prone  due  to  contamination  and
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Table  1  FDA  approved  commercially  available  molecular  assays.
Organism  Specimen  Assay  Method  Target  Sensitivity  (%)  Speciﬁcity  (%)
Human  papilloma
virus  (HPV)
Cervical  cytology
specimen
Digene  HC2  HPV
DNA  test
Hybridization
protection  assay
using  microplate
chemiluminesence
hybrid  capture  of
DNA—RNA  hybrid.
RNA  probe  cocktail  for
13  h  types
93.0  61.1
Chlamydia
trachomatis
Endocervical  and
vaginal  swabs
(female);
urethral  (males)
swabs
APTIMA  Assay  for
Chlamydia
trachomatis
Transcription
mediated
ampliﬁcation
23S  rRNA 95.6  98.8
Neisseria
gonorrhoeae
Cervical  and
vaginal  swabs
(female);
urethral  (males)
swabs
AMPLICOR  CT-NG
for  NG
PCR  M.NgoPII  putative
methyl  transferase
gene  of  NG
95.9—96.5  98.7—97.3
Human  immuno-
deﬁciency
virus-1  (HIV-1)
Plasma  separated
from  blood
collected  using
EDTA
COBAS
AmpliPrep/COBAS
TaqMan  HIV-1  test
and  COBAS
AmpliPrep/COBAS
TaqMan
Real-time  reverse
transcriptase-PCR
Gag  gene  48—10,000,000  copies/mL  (HIV-1  group  M)
Herpes  simplex
virus  (HSV)
Vaginal  lesion
swab
MultiCode  RTx
HSV  1&2  Kit
Real-time  PCR  using
isoC:isoG  synthetic
DNA  base  pair
technology
Glycoprotein  gene
segment  of  HSV-1  and
HSV-2
HSV-1,  92.4
HSV-2,  95.2
HSV-1,  98.3
HSV-2,  93.6
MRSA/SA
(screening,
surveillance)
Lesion  swab  from
skin/soft  tissue
Xpert  MRSA/SA
and  GeneXpert
System
Real-time  PCR  Staphylococcal  protein
A  (spa), the  gene  for
MecA-mediated
oxacillin  resistance
(mecA),  and  SCCmec
inserted  in  the  SA
chromosomal  attB  site
MRSA  positive
with  culture  93.8
SA  positive  with
culture  95.7
MRSA  negative
with  culture  97.3
SA  negative  with
culture  89.5
Clostridium
difﬁcile
Stool  sample Xpert  C.  difﬁcile
and  GeneXpert
Real-time  PCR C.  difﬁcile  tcdB 93.5  94.0
518
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Table  1  (Continued  )
Organism  Specimen  Assay  Method  Target  Sensitivity  (%)  Speciﬁcity  (%)
Enterococcus  Rectal  swabs Xpert  vanA  and
GeneXpert
System
Real-time  PCR Gene  sequences  for
VanA-encoded
resistance  to
vancomycin-teicoplanin
98.0  81.1—90.0
Organisms
causing  sepsis:
yeast
Smears  made
directly  from
yeast-positive
blood  cultures
Candida  albicans
PNA  FISH
PNA  FISH
species-speciﬁc
probes
16S  rRNA  of  C.  albicans 100  100
Group  A
Streptococcus
Throat  swabs  GAS  Direct  Test  Hybridization
protection  assay
rRNA  91.7  99.3
Mycobacteria Growth  from
solid  media  or
broth
AccuProbe  M.
avium
Hybridization
protection  assay
rRNA 99.3  100
AccuProbe
M.intracellula-re
100  100
Respiratory  virus
panel:  inﬂuenza
A  and  B  and  RSV
Nasopharyngeal
swab,  cultured
clinical
specimens
Verigene
Respiratory  Virus
Nucleic  Acid  Test
Multiplex  RT-PCR Inﬂuenza  A  matrix  gene  Inﬂuenza  A,  99.2  Inﬂuenza  A,  90.1
Inﬂuenza  B  NS  and
matrix  genes
Inﬂuenza  B,  96.8  Inﬂuenza  B,  98.5
L  and  F  genes  of  RSV  RSV,  89.8  RSV,  91.5
Enterovirus  CSF  Xpert  EV  and
GeneXpert
System
Real-time  PCR Consensus  region  of
enterovirus,  5′ UTR
between  nucleotides
452  and  596
96.3—100  97.0—97.2
Mycobacterium
tuberculosis
Sputum  and
bronchial
specimens
AMPLIFIED  MTD
Test
Transcription-
mediated
ampliﬁcation,
hybridization
protection  assay
Mycobacterial  16S  rRNA  96.9  100
Hepatitis  B  Virus
quantitative
EDTA plasma  or
serum
COBAS  TaqMan
HBV  Test
Real-time  PCR  Core—precore  region  of
the  HBV  genome;
primer  pairs  to
genotypes  A—G  of  HBV
and  the  precore
mutation
20—170,000,000  IU/mL
E elo
r
r
t
i
s
a
t
a
c
m
D
a
t
ﬂ
a
t
p
i
r
s
u
d
s
1
i
e
M
M
a
b
d
P
d
o
b
e
r
i
i
ﬁ
m
t
c
o
c
u
m
b
e
r
C
a
a
d
d
o
m
a
i
u
i
[
N
D
t
f
s
t
a
t
g
‘
a
s
A
t
m
t
t
F
c
i
a
t
r
c
[
M
d
M
d
m
t
a
d
t
c
T
t
o
cstablishing  molecular  microbiology  facilities  in  dev
equires  a  large  amount  of  sample  to  perform  the
eactions.  Utilizing  the  concept  of  both  spatial  and
emporal  microﬂuidic  PCR,  droplet-based  microﬂu-
dic PCR  formats  are  emerging  as  alternatives  to
ingle-phase  PCR.  Droplet  PCR  formats  have  many
dvantages,  such  as  low  reagent  usage,  faster
hermal cycling  and  limited  interactions  of  DNA
nd polymerase  with  the  channel  walls.  Carryover
ontamination can  be  reduced  using  these  for-
ats,  resulting  in  high  throughput  and  sensitivity.
roplets are  discrete  small  volumes  that  can  be
dapted  for  parallel  ampliﬁcation  in  small  concen-
rations.  There  are  a  number  of  pressure-driven
ow systems  that  use  microdroplets,  nanodroplets,
nd picodroplets  to  perform  both  PCR  and  reverse
ranscriptase PCR.  Many  commercially  available
roducts based  on  real-time  droplet  PCR  have  var-
ous applications,  such  as  absolute  quantiﬁcation,
are gene  identiﬁcation,  genomic  alterations,  and
ingle cell  analysis.  A  few  studies  have  reported  the
se of  droplet  PCR  for  the  diagnosis  of  infectious
isease agents  such  as  C.  trachomatis  (73.3%  sen-
itivity)  and  inﬂuenza  subtypes  (96%  sensitivity  and
00% speciﬁcity).  This  technique  can  be  adopted
n small  clinics  and  average  laboratories  [11,12],
specially in  resource  limited  countries.
ass spectrometry
ass  spectrometry  (MS)  was  recently  introduced
s a  new  diagnostic  technique  in  clinical  micro-
iology with  the  ﬁrst  successful  application  in
etection  and  sequence-based  identiﬁcation  of
CR products.  Based  on  MS,  matrix-assisted  laser
esorption/ionization  (MALDI)  coupled  with  time
f light  (TOF)  allows  the  analysis  of  various
iomolecules  in  microbes.  This  method  is  very
ffective and  requires  less  intense  sample  prepa-
ation  because  the  matrix  is  less  susceptible  to
nterference  from  salts  and  detergents.  MALDI-TOF
s an  extremely  useful  technique  for  the  identi-
cation of  many  microbial  species  because  the
ajor  mass  proﬁle  is  generated  from  ribosomal  pro-
eins that  align  perfectly  with  current  taxonomic
lassiﬁcations.  For  epidemiological  typing  studies
f bacterial  isolates,  mass  peaks  that  are  spe-
iﬁc to  a  given  strain  can  easily  be  identiﬁed  and
sed to  develop  a  binary  typing  system.  Further-
ore, substantial  resistance  mechanisms  can  also
e identiﬁed.  Cellular  modiﬁcations  under  the  inﬂu-
nce of  antibiotics  can  also  be  detected,  as  was
ecently  demonstrated  by  the  interaction  between
andida  albicans  cells  and  ﬂuconazole  and  Candida
nd Aspergillus  species  and  caspofungin.  Addition-
lly, MS  can  be  used  to  identify  PCR  products
erived from  resistance  genes.  The  iPLEX  MassArray
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eveloped  by  Sequenom  is  a very  good  example
f this  extensible  technology.  However,  there  are
any opposing  issue  with  this  diagnostic  MST.  The
ssays typically  require  104—105 cells,  which  are
nfrequently detected  in  patient  specimens  except
rinary tract  infections.  Moreover,  the  equipment
s very  expensive  and  needs  expensive  maintenance
13].
ucleic acid sequencing
NA  sequencing  is  already  used  in  many  diagnostic,
yping and  research  studies  and  is  particularly  use-
ul for  bacterial  identiﬁcation  based  on  16S  rRNA
equences.  Previously,  this  method  was  employed
o identify  short  nucleotide  sequences  of  PCR-
mpliﬁed products.  However,  with  advances  in
echnology  it  now  is  able  to  identify  complex
enome mixtures  of  bacteria  in  a  process  called
metagenomics’ and  can  generate  complete  cat-
logues  of  genomic  components  of  the  bacterial
pecies present  in  a variety  of  clinical  specimens.
lthough at  present,  it  remains  unclear  whether
his technology  is  suitable  for  routine  usage  in
icrobiology  laboratories,  metagenomics  is  essen-
ial for  understanding  the  effects  of  antibiotic
reatment of the  human  microbiome  as  a whole.
urthermore, next-generation  sequence  analysis
an facilitate  testing  of  host  susceptibility  toward
nfection  and  colonization  if  the  high  cost  of  the
pparatus  is  considered  to  be  a subsidiary  issue  for
he circumstances  of  each  individual  case.  This  cur-
ent basic  research  development  will  become  more
ommon  in  diagnostic  laboratories  in  coming  years
14].
icrobial volatile organic compound
etection
icrobial  volatile  organic  compounds  (MVOCs)  are
eﬁned as  a variety  of  compounds  formed  during
etabolism in  bacteria  and  fungi.  To  date,  more
han 200  different  MVOCs  have  been  identiﬁed,
nd the  diagnostic  relevance  of  MVOCs  has  been
escribed  in  the  literature.  However,  difﬁculties  in
he reproducibility  of  diagnostic  assays  and  the  con-
entrations  of  MVOCs  cannot  be  overlooked  [15].
he most  widely  used  MVOC  detection  technique  is
he micro-weighing  technique  using  vibration  meth-
ds, gas  chromatography  and  metal  chip  electrical
onductivity.  This  technology  has  been  developed
ased on  the  design  of  a system  that  allows  the
inetic measurement  of  MVOC  production  by  grow-
ng bacteria;  indeed,  several  bacterial  species  are
dentiﬁable  on  the  basis  of  their  MVOC  production
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proﬁle.  For  instance,  a  study  was  conducted  in
which the  diagnostic  speciﬁcities  varied  from  100%
for C.  difﬁcile  to  67%  for  Enterobacter  cloacae  [16].
This ﬁnding  suggests  that  the  diagnosis  capability  of
this technique  can  be  developed  in  the  future  for
use by  clinical  microbiology  laboratories.
Raman spectroscopic analysis
The  most  evident  contribution  of  spectroscopy  to
clinical microbiology  has  been  in  microbial  epi-
demiology.  In  recent  years,  Raman  spectroscopic
analysis (RSA)  has  been  validated  for  the  bacterial
typing of  different  species.  Although  RSA  has  been
proposed  to  be  capable  of  distinguishing  virtually
all bacterial  species,  deﬁnitive  data  are  missing.
RSA is  a  label-free,  optical  technology  based  on  the
non-elastic  scattering  of  light  by  the  molecules.  The
change in  wavelength  is molecule-speciﬁc  and  can
be displayed  in  a  Raman  spectrum.  These  changes
can be  seen  as  spectroscopic  ﬁngerprints  and  can
be used  to  visualize  the  comprehensive  molecular
composition. Several  studies  concluded  decisively
that the  typing  of  different  strains  belonging  to
a single  species  can  be  performed  appropriately.
The molecular  typing  of  various  species  such  as
E. coli,  Pseudomonas  aeruginosa, Staphylococcus,
and Klebsiella  pneumoniae  produced  similar  results
that were  equal  in  quality  to  other  gold  standard
techniques [17].
Nanoparticles
A  variety  of  methods  have  been  introduced  into
clinical microbiology  over  the  course  of  the  last
decade.  These  methods  clearly  meet  some  diag-
nostic standards  and  development  is  continuing.
Moreover, many  new  technologies  are  making  their
way into  diagnostic  microbiology,  such  as  cell-based
biosensors  in  the  area  of  ‘nanodiagnostics’.  This
technology  uses  cells  as  biochemical  detectors  with
high sensitivity  and  speciﬁcity.  Furthermore,  there
has been  an  emergence  of  ‘theranostics’,  which
appropriately combines  attributes  of  diagnostics
and therapy  to  ﬁght  against  infection.  Recently,  sil-
ver nanoparticles  (a  noble  metal  known  to  exhibit
strong toxic  effects  against  microbes  and  less  tox-
icity to  humans)  have  been  tested.  A  recent  study
[18]  using  electron  microscopy  revealed  ‘pits’  in  the
cell walls  of  E.  coli  and  other  microbes  that  were
caused by  the  accumulation  of  silver  nanoparticles.
These ‘pits’  resulted  in  the  alteration  of  membrane
morphology and  increased  membrane  permeability,
leading to  cell  death.  Thus,  this  study  clearly  exem-
pliﬁes the  role  of  nanoparticles  in  circumventing
the forthcoming  threat  of  bacterial  infections.
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Although  there  are  numerous  beneﬁts  of  molec-
lar techniques,  the  advantages  of  many  conven-
ional methods  should  not  be  overlooked.  Currently,
 well-equipped  microbiology  laboratory  should
ave both  reliable  conventional  methods  and  new
olecular  techniques,  and  staff  should  focus  on
ssues such  as  cost,  performance,  durability  and
aintenance.
aboratory facilities in developing
ountries
he  quality  of  the  laboratory  service  depends
pon various  fundamental  strategies,  including
dequately trained  laboratory  staff,  management
f the  physical  laboratory  infrastructure,  good  lab-
ratory practices,  strict  quality  control,  quality
ssurance  programs,  and  investment  into  new  and
mproved technology  [19]. However,  in  many  devel-
ping countries  there  is  scarcity  of  basic  policies
equired for  a  quality  functional  laboratory.  Labo-
atory settings  without  proper  infrastructure  pose
he greatest  challenge  for  adequate  performance.
 lack  of  clean  water  and  inadequate  supply  of  elec-
ricity  and  cold  storage  immensely  limit  the  quality
f laboratory  procedures  [20].
aboratory management
he  management  of  a  high-quality  clinical  micro-
iology  laboratory  is  crucial  for  the  control  of
ospital  and  community  acquired  infections.  Due
o the  lack  of  expertise  in  managing  clinical  micro-
iology  laboratories  in  developing  countries,  there
hould be  international  guidance  or  training  for
he staff;  if  possible,  training  programs  should  be
onducted  by  high-quality  laboratories  from  devel-
ped countries.  Careful  review  of  the  available
esources, foundation  and  facilities  would  expedite
he available  support  required.  Furthermore,  vis-
ting various  established  laboratories  that  perform
dentical  work  can  provide  important  information
20]. Evaluation  and  accreditation  of  the  labora-
ory  is also  important;  however,  this  process  is
ependent  on  the  overall  cost  and  available  fund-
ng. Laboratory  administration  should  take  care  of
heir internal  staff  and  external  communication  sys-
ems. The  staff  should  receive  medical  evaluation
n case  of  emergency,  and  medical  records  main-
enance should  be  performed  appropriately  [7].
ffective communication  between  the  laboratory
nd health  care  providers  should  be  supported,
specially with  the  physician.  Because  the  shared
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ostablishing  molecular  microbiology  facilities  in  dev
nformation  is  both  qualitative  and  analytical,  ade-
uate provision  for  bidirectional  interactions  should
e maintained.  Telephone,  email,  facsimile  and
entral laboratory  information  systems  are  useful
or documentation  [21].
aboratory networking systems
etworking  between  laboratories  may  increase
nfection surveillance  within  a  huge  geographi-
al region.  The  WHO  supports  the  establishment
f national  networks  for  the  regular  exchange  of
nformation  and  proper  support  for  the  labora-
ory. However,  only  a  few  countries  have  national
nd international  laboratory  networks  [22]. The
stablishment  of  an  integrated  laboratory  system
s very  important  to  combat  many  infectious  dis-
ases. However,  integrated  systems  are  ﬁnancially
eglected  in  developing  countries.  Strengthening
aboratory systems  in  developing  countries  requires
ffective  strategic  plans  involving  (a)  legal  and  pol-
cy framework,  (b)  institutional  and  management
ramework, (c)  human  resources,  (d)  laboratory
uality management,  (e)  evaluation  and  moni-
oring,  (f)  maintenance  of  equipment,  and  (g)
aboratory  structure  and  design  [23].
aboratory biosafety and risk
ssessment
linical  microbiology  laboratories  expose  their  staff
nd the  public  to  various  clinical  samples,  which
ay  include  various  biohazards  such  as  infectious
iseases. Therefore,  it  is  important  to  develop  a
iosafety  management  program  or  operational  plan
or the  laboratory  with  regular  training  schemes,
hereby ensuring  the  use  of  standard  practices  and
rocedures.  Laboratory  facilities  are  designed  to
eet certain  biosafety  levels  that  have  designated
onstructional designs,  containment  accessibili-
ies, equipment,  operations  and  procedures  that
re employed  for  risky  biological  agents.  Sample
ollection, transportation,  handling,  labeling  and
dentiﬁcation  should  be  performed  according  to
HO recommendations  [24]. A  laboratory  biosafety
lan should  be  maintained  to  reduce  any  accidental
elease of  biohazardous  material.  The  compre-
ensive plan  should  include  working  guidelines,
rimary care  designs  such  as  protective  equipment
nd biosafety  cabinets,  and  secondary  care  designs
ncluding  laboratory  facilities.  Furthermore,  the
iosafety  plan  should  promote  the  prevention  of
aboratory-associated  infections  and  environmental
f
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rotection.  A  biosafety  committee  should  be  estab-
ished to  gauge  the  success  of  the  biosafety  plan  by
mplementing  and  enforcing  laboratory  protocols
nd encouraging  strict  adherence  to  safety  guide-
ines. Because  the  identity  of  infectious  agents
emains unknown  during  the  initiation  of  microbial
nvestigations, biosafety  level-2  is  recommended
or clinical  microbiology  laboratories  [25,26].
aboratory accreditation
edical  laboratories  are  regulated  by  government
odies and  strengthened  by  the  standards  validated
y other  professional  organizations.  Accreditation
s an  assessment  process  performed  by  an  autho-
ized body  to  ensure  quality  control  and  the
ssurance of  the  laboratories.  This  process  pro-
ides formal  recognition  that  the  laboratory  can
erform  quality  experiments.  Laboratories  test-
ng human  samples  for  the  diagnosis,  prevention
r treatment  of  diseases  are  within  the  scope
f the  assessment  [27].  All  of  the  accredita-
ion regulations  are  developed  through  consensus,
ollaboration and  consultation  of  health  care
rofessionals and  health  care  authorities.  The
aboratory  standards  are  monitored  by  on-site
nspection, management  requirements  for  patient
esting,  and  follow-up  actions.  Although  there  are
ifferences  in  accreditation  service  procedures
nd programs,  the  overall  assessment  remains
he same  [28]. The  international  organization
or standardization  (ISO)  is  a global  organiza-
ion for  national  standards  that  is  comprised  of
40 members  across  the  globe.  The  International
ccreditation  Forum  (IAF)  and  the  International
aboratory Accreditation  Cooperation  (ILAC)  deal
peciﬁcally  with  laboratories.  The  ILAC  commis-
ions tasks  local  bodies  such  as  the  Asia  Paciﬁc
aboratory Accreditation  Cooperation  (APLAC)  in
sia using  ISO  standards  [29]. The  standard  guide-
ines for  regulating  quality  laboratory  management
re included  in  ISO  15189:2007,  which  can  be
btained from  the  ISO  website  (http://www.
so.org/iso/catalogue  detail?csnumber=42641).
aboratory design
he  establishment  of  a  clinical  microbiology  lab-
ratory in  low-resource  countries  requires  the
ollowing  strategies:  (a)  requirement  for  physical
nfrastructure,  (b)  various  assays,  (c)  supplemen-
ation of reagents,  (d)  provision  of  equipment
nd maintenance,  and  (e)  dedicated  working
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stations.  In  developing  countries,  these  key  points
are usually  overlooked  due  to  other  issues.  The
main requirement  for  designing  a  microbiology
laboratory  is  a  clean  and  well-controlled  environ-
ment [30].  Surfaces  contaminated  with  dust  and
aerosols  and  humid  areas  will  be  hazardous  for
the microbiological  procedures.  Mechanical  ven-
tilation  systems  providing  inward  ﬂow  of  air  are
recommended  to  provide  containment  zones  with
increased  negative  pressure.  The  reliable  supply
and  maintenance  of  gas  and  a  standby  electricity
generator are  preferred.  Special  attention  should
be paid  to  the  huge  volume  of  microbes,  overcrowd-
ing equipment,  infestation  and  unauthorized  entry.
Other laboratory  features  must  also  be  addressed,
such as  dead  space  areas  with  no  airﬂow  and  low
ceilings that  prevent  the  exclusion  of  contamina-
tion during  microbiology  procedures  [26]. Waste
pipes, drainage,  and  ventilation  systems  manag-
ing contaminated  material  should  be  maintained
efﬁciently. Even  building  material,  such  as  a leak-
ing roof  that  causes  moisture,  could  be  sources  of
contamination.  The  location  of  heavy  equipment
should facilitate  the  cleaning  of  the  laboratory
walls and  ﬂoors  or  may  be  placed  on  mobile
benches [31]. Illumination  should  be  appropriate
for the  safe  conduct  of  laboratory  work.  Storage
should be  appropriate  for  all  supplies,  reagents,
hazardous chemicals  and  radioactive  materials.  A
holding zone  for  laboratory  garments  such  as  aprons
and lab  coats  should  be  placed  outside  or  possibly
at the  entrance  of  the  laboratory.  Hand  hygiene
basins should  be  provided  at  the  entry  and  exit
points with  alcohol  rubs.  Eating  and  drinking  should
not be  permitted  within  the  laboratory  because
these activities  may  serve  as  the  main  source
of contamination.  If  possible,  every  room  in  the
laboratory  should  have  hand  glove  stations  and
medical  waste  collection  bags.  Doors  should  have
vision panels,  be  self-closing  and  have  ﬁre  rat-
ings [32].  Although  there  is  no  special  guideline
for the  manner  in  which  the  space  in  a labo-
ratory is  used,  an  area  of  350  ft/person  within
the laboratory  would  enable  worker  safety  [26].
The high  risk  of  specimen—specimen  contact  when
performing  PCR-based  assays  requires  specialized
set-up. Four  different  physically  separated  work-
ing areas  are  recommended,  including  an  area  for
reagent  preparation,  PCR  master  mix  preparation,
nucleic acid  processing  and  an  ampliﬁcation  area.
All of  these  working  spaces  should  be  kept  free  of
all other  patient  specimens  [2]. Post-ampliﬁcation
and ultraviolet  (UV)  photography  should  be  per-
formed  in  specialized  rooms  with  a  UV  containment
area. The  use  of  UV  aprons  should  be  made
mandatory within  this  area.  The  equipment  used
t
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ithin  UV  area  should  not  be  used  outside  of  the
rea.
aboratory equipment
n  resource-limited  settings,  there  is  lack  of
ecentralized  molecular  diagnostic  testing  and
parse access  to  centralized  medical  facilities.
ecause many  molecular  technique  apparatuses
re expensive  to  install  in  average  microbiol-
gy laboratories,  cost-effective  equipment  can  be
sed. Portable  molecular  technologies  especially
esigned for  developing  countries  are  available;
or example,  portable  nucleic  acid  thermocy-
lers are  battery  powered  and  cheaper  than
ench top  units.  These  portable  thermocyclers
an perform  PCR,  reverse  transcriptase-PCR  and
any formats  of  isothermal  ampliﬁcation,  includ-
ng nucleic  acid  sequencing-based  ampliﬁcation,
trand displacement  ampliﬁcation,  rolling  circle
mpliﬁcation,  loop-mediated  isothermal  ampliﬁca-
ion, and  helicase-dependent  ampliﬁcation.  There
re valuable  applications  of  these  portable  ther-
ocyclers  in  diagnostic  microbiology  and  biothreat
etection.  Various  infectious  agents  have  been
dentiﬁed  using  these  portable  apparatuses,  such  as
PV, N.  gonorrhoeae, C.  trachomatis, Treponema
allidum and  T.  vaginalis  [33]. Several  varieties  of
ortable apparatuses  are  commercially  available;
mportant evaluation  criteria  for  each  technology
nclude maturity,  power  requirements,  cost,  sen-
itivity, speed,  and  manufacturability.  Ultimately,
he needs  of  a particular  market  will  lead  to  user
equirements  that  drive  the  decision  between  avail-
ble technologies.
There is  a  serious  issue  with  instrument  mainte-
ance in  developing  countries  because  the  lack  of
unctional  equipment  will  decrease  the  efﬁcacy  and
uality of  the  laboratory  procedures  [22].  For  qual-
ty assurance,  the  facility  should  have  documented
rocedures for  the  maintenance,  calibration,  ver-
ﬁcation and  validation  of all  equipment.  Various
uccessful  infection  control  programs  have  come  to
 halt  in  a number  of  developing  countries  due  to
he lack  of  maintenance  and  service  of  the  labora-
ory  equipment.  Equipment  failure  and  breakdown
elays laboratory  output;  thus,  equipment  main-
enance  should  be  given  priority.  Selection  of
quivalent  brands  is  important  and  depends  on  the
ervice provided  by  the  local  dealer  [19]. Some-
imes it  is wiser  to  buy  simple  instrumentation
hat is  user  friendly  and  less  expensive  rather
han opting  for  automated  instruments.  Sophisti-
ated electric  equipment  must  also  be  avoided
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n  developing  countries  unless  it  is  essential  due
o the  irregular  supply  of  electricity  and  the  high
ost.
Furthermore,  the  laboratory  staff  should  receive
n-site training  for  equipment  by  the  manufacturer
34].  Thermocyclers  are  important  instruments  for
olecular microbiology  laboratories;  any  change
n the  performance  of  thermocyclers  will  directly
ffect the  precision  of  the  tests.  Determination
nd documentation  of  cycling  time  or  any  errors
hould be  recorded;  ﬂuctuations  in  the  cycling
imes should  serve  as  warnings  and  be  adjusted.
dditionally, chiller,  heater  and  block  tempera-
ure adjustments  should  be  performed  according  to
he manufacturer’s  recommendations  [35].  Pipettes
nd micro-pipettes  are  used  in  almost  every  step
f routine  procedures;  therefore,  special  atten-
ion should  be  paid  to  their  usage  because  they
re the  prime  source  of  errors.  Pipette  calibrations
hould be  performed  regularly  using  recommended
uidelines. Special  care  should  be  given  to  the
FGE  apparatus,  with  proper  cleaning  of  the
ank performed  before  and  after  every  run  and
he electrodes  changed  regularly.  Most  molecu-
ar instruments  are  expensive.  Recently,  a  reagent
ental agreement  program  has  been  introduced  as  a
eans to  acquire  molecular  instruments;  however,
he availability  of  this  program  depends  upon  the
anufacturer  [36].
aboratory practice
eneral  laboratory  practice  requires  careful  atten-
ion, including  regular  cleaning  and  strict  monitor-
ng of  all  methods  performed.  The  practice  code
s a  list  of  the  most  essential  procedures  used
n basic  good  microbiology  practices.  It  is  impor-
ant to  develop  written  laboratory  practices  and
ethods  for  safe  laboratory  operations.  Interna-
ional biohazard  signs  must  be  displayed  on  the
aboratory  door  if  the  laboratory  is  working  with
solates  from  risk  group  2 or  above.  Only  authorized
ersonnel should  be  given  access,  and  laboratory
oors should  always  be  closed.  All  of  the  surface
reas should  be  cleaned  before  and  after  usage.
orking stations,  tables,  refrigerators  and  reagent
ontainers  should  be  regularly  swabbed  with  70%
thyl alcohol  [37].  The  use  of  disinfectants  recom-
ended  by  the  environmental  protection  agency
hould  be  promoted.  Cleaning  should  be  performed
n all  surfaces,  benches,  racks,  tiles,  rockers  and
herever  a  spill  occurs.  For  molecular  procedures
especially PCR  and  PFGE),  each  working  area
hould contain  dedicated  reagents,  materials  and
b
s
s
bping  countries  523
ipetting  devices.  Reagents  should  be  prepared  in
mall aliquots  to  avoid  contamination  [3].
aboratory personnel requirement
ncreasing  the  number  of  well-trained  and  skilled
ersonnel is  a major  limitation  in  developing
ountries. Although  there  is  a  steady  demand  for
ppropriate  and  adequate  workers,  governmen-
al policies  restrict  the  ﬂow  of  skills.  Laboratory
ersonnel should  be  trained  with  all  safety  meas-
res. Updating  staff  about  the  control  measures
or laboratory  biohazards  is a  key  to  preventing
aboratory-acquired  infections.  An  effective  labo-
atory program  should  be  introduced  by  integrating
afe laboratory  practices  into  the  basic  training
f the  personnel  [38]. Training  should  include  all
afety measures  for  handling  hazardous  materials,
uch  as  aerosol  inhalation,  ingestion  of  specimens,
ercutaneous exposure  to  sharp  instruments,  and
andling  and  disposal  of  hazardous  material.  The
kills required  for  molecular  techniques  are  more
recise  and  include  micro-pipetting,  DNA  handling
nd disposal,  software  manipulation  during  analysis
f the  results  and  reporting  [26]. Personal  protec-
ive equipment  should  always  be  used  as  a  ﬁrst  line
f safety:
) Protective  laboratory  coats  must  be  worn  at  all
times inside  the  laboratory.
) Hand  protection  should  be  followed  by  wearing
disposable gloves  made  of  nitrile  or  chloroprene.
) Eye  and  face  protection  should  be  made  com-
pulsory whenever  a splash  or  spill  occurs.
aste management
n  most  low-income  regions  and  especially  in  Asian
ountries  the  management  of  medical  waste  is  a
evere problem;  only  a  handful  of  centers  can
rocess medical  waste  efﬁciently.  Waste  gener-
ted by  microbiology  laboratories  in  the  form  of
pecimen  samples,  culture  plates  and  tubes  all
arry a  high  potential  risk  of  infection  and  need
o be  managed  effectively.  Most  of  the  biomed-
cal waste  produced  should  be  decontaminated,
iscarded  or  incinerated  [39].  Non-infectious  mate-
ials such  as  glassware  are  recyclable  and  can  be
terilized.  Decontamination  should  be  performed
y steam  autoclaving.  Contaminated  sharp  wastes,
uch as  hypodermic  needles,  disposable  knives,  and
yringes,  should  be  discarded  in  a puncture-proof
ag [32].
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Prospective instructions
Due  to  the  lack  of  ﬁnancial  resources  in  develop-
ing countries,  partnerships  between  public,  private
and commercial  sectors  should  be  maintained  in
order to  build  a  well-equipped  laboratory.  Fund-
ing bodies  should  address  the  ﬁnancial  inequity,
and an  appropriate  balance  should  be  encouraged
that emphasizes  laboratory  infrastructure  and  man-
agement.  There  should  be  a  focus  on  accurate
identiﬁcation  and  the  use  of  highly  reproducible
methods. The  funding  bodies  should  target  long-
term training  and  education  of  future  laboratory
personnel. There  should  be  improved  communica-
tion between  the  laboratory  and  clinicians,  which
could affect  the  accuracy  of  disease  treatment.
Policy makers  and  health  care  personnel  must
understand that  accurate  and  rapid  identiﬁcation
are important  for  the  prevention  and  treatment  of
disease. It  is  very  important  to  maintain  a well-
maintained clinical  microbiology  laboratory  using
current knowledge  to  control  infections.  Build-
ing a  molecular  microbiology  laboratory  facility  to
provide rapid,  accurate  and  reliable  tests  will  help
health care  staff  to  deliver  more  effective  treat-
ment regimens,  thereby  reducing  mortality,  overall
expenditure  of  health  care  resources  and  improv-
ing the  quality  of  health  care  services  in  developing
countries.
Funding
No  funding  sources.
Competing interests
None  declared.
Ethical approval
Not  required.
References[1] Whelen AC, Persing DH. The role of nucleic acid ampliﬁca-
tion and detection in the clinical microbiology laboratory.
Annu Rev Microbiol 1996;50:349—73.
[2] McGowan JE, Metchock BG. Basic microbiologic support
for hospital epidemiology. Infect Control Hosp Epidemiol
1996;17(5):298—303.
[
[S.S.  Ahmed  et  al.
[3] Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter
EA, et al. Real-time PCR in clinical microbiology: appli-
cations for routine laboratory testing. Clin Microbiol Rev
2006;19(1):165—256.
[4] Ulu-Kilic A, Ahmed SS, Alp E, Doganay M. Challenge of
ICU-acquired infections and Acinetobacter baumannii in
developing countries. OA Crit Care 2013;1(1):2.
[5] Archibald LK, Reller LE. Clinical microbiology in developing
countries. Emerg Infect Dis 2001;7(2):302—5.
[6] Malkin R, Keane A. Evidence-based approach to the main-
tenance of laboratory and medical equipment in resource-
poor settings. Med Biol Eng Comput 2010;48(7):721—6.
[7] Sibley CD, Peirano G, Church DL. Molecular methods for
pathogen and microbial community detection and charac-
terization: current and potential application in diagnostic
microbiology. Infect Genet Evol 2012;12(3):505—21.
[8] Pfaller MA, Herwaldt LA. The clinical microbiology
laboratory and infection control: emerging pathogens,
antimicrobial resistance, and new technology. Clin Infect
Dis 1997;25(4):858—70.
[9] Tang YW, Procop GW, Persing DH. Molecular diagnostics of
infectious diseases. Clin Chem 1997;43(11):2021—38.
10] Niemann J, Tietze E, Ruddat I, Fruth A, Prager R, Rabsch W,
et al. Epidemiological analysis of the dynamic and diversity
of Salmonella spp. in ﬁve German pig production clusters
using pheno- and genotyping methods: an exploratory study.
Vet Microbiol 2014;176:190—5.
11] Angione SL, Inde Z, Beck CM, Artenstein AW, Opal SM,
Tripathi A. Microdroplet sandwich real-time rt-PCR for
detection of pandemic and seasonal inﬂuenza subtypes.
PLOS ONE 2013;8(9):e73497.
12] Schachter J. Will droplet digital PCR become the test
of choice for detecting and quantifying ocular Chlamydia
trachomatis infection? Maybe not. Expert Rev Mol Diagn
2013;13(8):789—92.
13] van Belkum A, Durand G, Peyret M, Chatellier S, Zambardi
G, Schrenzel J, et al. Rapid clinical bacteriology and its
future impact. Ann Lab Med 2013;33(1):14—27.
14] Lam HY, Clark MJ, Chen R, Chen R, Natsoulis G,
O’Huallachain M, et al. Performance comparison of
whole-genome sequencing platforms. Nat Biotechnol
2012;30(1):78—82.
15] Korpi A, Jarnberg J, Pasanen AL. Microbial volatile organic
compounds. Crit Rev Toxicol 2009;39(2):139—93.
16] Bruins M, Bos A, Petit PLC, Eadie K, Rog A, Bos R, et al.
Device-independent, real-time identiﬁcation of bacterial
pathogens with a metal oxide-based olfactory sensor. Eur
J Clin Microbiol Infect Dis 2009;28(7):775—80.
17] Willemse-Erix D, Bakker-Schut T, Slagboom-Bax F, Jachten-
berg J, Toom NL, Papagiannitsis CC, et al. Rapid typing of
extended-spectrum beta-lactamase- and carbapenemase-
producing Escherichia coli and Klebsiella pneumoniae
isolates by use of SpectraCell RA. J Clin Microbiol
2012;50(4):1370—5.
18] Shinde SB, Fernandes CB, Patravale VB. Recent trends in in-
vitro nanodiagnostics for detection of pathogens. J Control
Release 2012;159(2):164—80.
19] Abimiku AG. Building laboratory infrastructure to support
scale-up of HIV/AIDS treatment, care, and prevention: in-
country experience. Am J Clin Pathol 2009;131(6):875—86.
20] Mickey U, Penny LA, Olmsted SS, Giovanni MY, Kaspar P,
Shepherd A, et al. Requirements for high impact diagnostics
in the developing world. Nature 2006;444(Suppl. 1):73—9.21] van Belkum A, Tassios PT, Dijkshoorn L, Haeggman S, Cook-
son B, Fry NK, et al. Guidelines for the validation and
application of typing methods for use in bacterial epidemi-
ology. Clin Microbiol Infect 2007;13(Suppl. 3):1—46.
E elo
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[stablishing  molecular  microbiology  facilities  in  dev
22] Masanza MM, Nqobile N, Mukanga D, Gitta SN. Laboratory
capacity building for the International Health Regulations
(IHR[2005]) in resource-poor countries: the experience of
the African Field Epidemiology Network (AFENET). BMC
Public Health 2010;10(Suppl. 1):S8.
23] Nkengasong JN, Mesele T, Orloff S, Kebede Y, Fon-
jungo PN, Timperi R, et al. Critical role of developing
national strategic plans as a guide to strengthen laboratory
health systems in resource-poor settings. Am J Clin Pathol
2009;131(6):852—7.
24] Zaki AN. Biosafety and biosecurity measures: management
of biosafety level 3 facilities. Int J Antimicrob Agents
2010;36(Suppl. 1):S70—4.
25] Sargent EV, Gallo F. Use of personal protective equipment
for respiratory protection. ILAR J 2003;44(1):52—6.
26] Miller JM, Astles R, Baszler T, Chapin K, Carey R, Garcia L,
et al. Guidelines for safe work practices in human and ani-
mal medical diagnostic laboratories. Recommendations of
a CDC-convened, Biosafety Blue Ribbon Panel. Morb Mortal
Wkly Rep 2012;61(Suppl.):1—102. Surveillance summaries.
27] Bachner P. The impact of regulations, accreditation stan-
dards, and ‘healthcare reform’ on laboratory practice in
the United States. Pure Appl Chem 1996;68(10):1847—9.
28] Burnett D. ISO 15189: 2003 — quality management, eval-
uation and continual improvement. Clin Chem Lab Med
2006;44(6):733—9.
29] Wadhwa V, Rai S, Thukral T, Chopra M. Laboratory qual-
ity management system: road to accreditation and beyond.
Indian J Med Microbiol 2012;30(2):131—40.
[
Available  online  at  www
ScienceDping  countries  525
30] Birx D, de Souza M, Nkengasong JN. Laboratory challenges
in the scaling up of HIV TB, and malaria programs: the inter-
action of health and laboratory systems, clinical research,
and service delivery. Am J Clin Pathol 2009;131(6):849—51.
31] Smith L, Lowdell MW. Quality issues in stem cell and
immunotherapy laboratories. Transfus Med 2003;13(6):
417—23.
32] Anonymous, editor. Laboratory bios manual. 3rd ed. World
Health Organization; 2004. p. 10—4.
33] Chang CC, Chen CC, Wei SC, Lu HH, Liang YH, Lin CW. Diag-
nostic devices for isothermal nucleic acid ampliﬁcation.
Sensors (Basel) 2012;12(6):8319—37.
34] Inamdar MS, Healy L, Sinha A, Stacey G. Global solutions
to the challenges of setting up and managing a stem cell
laboratory. Stem Cell Rev 2012;8(3):830—43.
35] Linz U. Thermocycler temperature variation invalidates
PCR results. Biotechniques 1990;9(3), 286, 288, 290—3.
36] Baron EJ. Implications of new technology for infectious dis-
eases practice. Clin Infect Dis 2006;43(10):1318—23.
37] Adamo JE, Bauer G, Berro M, Burnett BK, Hartman KA,
Masiello LM. A roadmap for academic health centers to
establish good laboratory practice-compliant infrastruc-
ture. Acad Med 2012;87(3):279—84.
38] Baron EJ, Miller JM. Bacterial and fungal infections among
diagnostic laboratory workers: evaluating the risks. Diagn
Microbiol Infect Dis 2008;60(3):241—6.39] Chitnis V, Vaidya K, Chitnis DS. Biomedical waste in lab-
oratory medicine: audit and management. Indian J Med
Microbiol 2005;23(1):6—13.
.sciencedirect.com
irect
